The 6th Biennial Meeting of the Asian Society of Gynecologic Oncology October 10th to 12th 2019

摘要

According to GLOBOCAN database for 2018, 637,761 (48.7%) new gynecologic cancer cases and 305,000 (50.1%) gynecologic cancer deaths were observed in Asia [ ]. The difference between Asian women and non-Asians concerning genetic background, cancer epidemiology, disease characteristic, and socio-cultural environment has been well recognized. However, most of the experimental evidence to guide clinical gynecologic oncology practice have traditionally been derived from studies in western population. Asian Society of Gynecologic Oncology (ASGO) was founded in 2008 as the principal organization in Asia contributing to the study, prevention, and treatment of gynecological cancer by means of scientific exchange, regional/international collaboration, provision of educational opportunities, and strengthening friendship among members [ ]. Currently, ASGO has members in over 10 countries in Asia.